Advisory · Ophthalmology
Gene therapy and sustained delivery are the premium deal drivers.
Ambrosia provides senior-led advisory for ophthalmology licensing, M&A, and strategic partnerships — backed by a proprietary database of 75 verified ophthalmology transactions.
Deal Landscape
What ophthalmology transactions actually look like.
Verified Transactions
75
Median Upfront
$52M
Key Structure Insight
Sustained delivery platforms command platform-level economics in ophthalmology
Stay Informed
Get new deal intelligence and transaction insights as we publish them.
No spam. Unsubscribe anytime.
Discuss your ophthalmology transaction.
We’ll meet you at peer level — anywhere in the world.